CARB - Carbonite, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
14.25
-0.23 (-1.59%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close14.48
Open14.58
Bid0.00 x 900
Ask0.00 x 1400
Day's Range14.15 - 14.73
52 Week Range14.14 - 43.63
Volume557,031
Avg. Volume638,276
Market Cap486.476M
Beta (3Y Monthly)0.57
PE Ratio (TTM)N/A
EPS (TTM)-0.24
Earnings DateOct 30, 2019 - Nov 4, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est26.56
Trade prices are not sourced from all markets
  • GlobeNewswire

    SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CAH, CARB, GTT, VNTR INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

    NEW ORLEANS, Aug. 19, 2019 -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending.

  • ACCESSWIRE

    CLASS ACTION UPDATE for VNTR, CARB and CURLF: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

    NEW YORK, NY / ACCESSWIRE / August 19, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine ...

  • ACCESSWIRE

    CARB LOSS NOTICE: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Carbonite, Inc.; Encourages Investors with Losses Over $100K to Come Forward - CARB

    New York, NY / ACCESSWIRE / August 19, 2019 / Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Carbonite, Inc. ...

  • ACCESSWIRE

    The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PVTL, CARB and EVH

    NEW YORK, NY / ACCESSWIRE / August 19, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate ...

  • ACCESSWIRE

    Carbonite, Inc. (CARB), Cardinal Health, Inc. (CAH) & Just Energy Group Inc. (JE) - Bronstein, Gewirtz & Grossman, LLC - Class Action Reminder

    NEW YORK, NY / ACCESSWIRE / August 19, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review ...

  • Should You Buy These 3 Beaten-Down Stocks Now?
    TipRanks

    Should You Buy These 3 Beaten-Down Stocks Now?

    Buy low and sell high – it’s an old saw, true, but it’s still the surest way to turn a profit in the markets. The hard part, of course, is knowing just what to buy when it’s low. Not all low-cost stocks are created equal, and a savvy investor needs to know how to sort out the potential winners for his portfolio.Here, we look at three stocks have taken a beating in recent months but retain their Buy rating. The reasons vary, as do the industries and business models, but all three have three features in common: an entry cost below $15 per share, a low-end price target well above the current share price, and a huge upside potential.Let's take a closer look:Carbonite, Inc. (CARB)The cloud backup company took two hard hits at the end of last month, when it reduced full-year revenue and earnings guidance the same week that CEO Mohamad Ali announced his pending departure. Investors generally don’t like getting reams of bad news all at once, and CARB shares fell from $23.90 to $18.01. The stock has been slipping slowing ever since, and currently stands at $14.48.There was good news, however. Q2 GAAP revenues jumped to $121.5 million, a gain of 56%, and the adjusted EPS of 56 cents was 16% higher than the 47-cent expectation. Gross margins improved, too, from 77.1% in the year-ago quarter to 82.3% in Q2 2019.While the CEO has left, his place has been taken on an interim basis by Board chairman Steve Munford. In a statement on the company’s path forward, Munford said, "We remain committed to capitalizing on the opportunity of combining data protection and security, while we improve the effectiveness of our go-to-market efforts and deliver on our profitability targets." It’s a good note of continuity, which investors like.Some of Wall Street’s top analysts also like what they see in Carbonite, although they are cautious enough to lower their price targets. Northland Capital Markets’ Tim Klasell, a 5-star analyst, says, “We are reducing our top line in response [to Q2 revenue numbers], but cost synergies from the Webroot acquisition are protecting the bottom line. The CEO has left for a new opportunity, which raises the possibility of a strategic move.” With the company’s bottom line safe for now, and the way open for new ideas at the top, Klasell gives CARB a Buy rating with a $30 price target, suggesting a 107% upside from current levels. (To watch Klasell's track record, click here)John DiFucci, of Jefferies, is more cautious but still bullish. He has lowered his price target from $37 to $29, but still sees a 100% upside to the stock. He describes Carbonite as “Consistently Inconsistent,” but adds that, “the stick will work if the company can hit numbers and the post-earnings selloff brings an attractive valuation.” DiFucci is also a 5-star analyst, and rated 27 overall in the TipRanks database.Carbonite’s analyst consensus is a Moderate Buy, based on 5 buys, 2 holds, and 1 sell. The average price target of $26.75 gives an upside potential of 84% from the current share price of $14.48.Kala Pharmaceuticals, Inc. (KALA)Our next example of an undervalued stock with great potential is KALA. A small-cap pharma company, Kala Pharmaceuticals released its first drug – Inveltys, an eye drop to relieve pain and swelling after ocular surgery – to the markets early this year, and analysts expect its annual sales will peak near $300 million. Not bad, for a company with a market cap of just $136 million.So why has KALA’s share price dropped 71% in the past 12 months, from its peak at $13.87 last August to just $4 at Friday’s close?The answer may lie in the nature of biopharma investing, and the heightened expectations around the sales of new drugs. Inveltys’ slow start in the market is hardly out of the ordinary; medical research and drug development are capital intensive, and it generally takes several quarters before a new pharmaceutical begins to turn a profit. The investors are not worried about Kala’s red ink, so much as they are worried by the disparity between the $2.06 million in Q2 Inveltys revenue and the $2.69 million of the average estimate. Going forward, profit estimates grow, reaching $14 million for full-year 2019 and over $70 million for 2020. By the early indications, Inveltys will have difficulty meeting those numbers.On the other hand, prescription numbers are moving in the right direction. Kala disclosed 11,000 Inveltys scrips in Q1, and 31,000 in Q2. The June quarter ended with Inveltys holding 6.8% market share in a crowded environment. More importantly, insurance plans covering a total of 92 million people have added Inveltys to their benefits lists.Several Wall Street analysts see Kala’s growth potential outweighing its near-term risk. Speaking for the bulls, H. C. Wainwright’s Yi Chen says, “In our view, INVELTYS still has plenty of room for growth within the market of 4.8M cataract surgery procedures each year in the U.S. However, we have lowered the growth rate for INVELTYS revenue to reflect current market conditions given the entry of new competitors into the marketplace.” He may be cautious, but his price target and upside reflect the profit potential of the biopharma industry; at $12, the target suggests a 200% upside. (To watch Chen's track record, click here)Wedbush analyst Liana Moussatos agrees with Chen about KALA’s potential, and then some. Writing, “We reiterate our OUTPERFORM rating,” she sets a 12-month price target of $51, implying a whopping 1,175% upside to the shares.Despite KALA’s near-term risk, the stock holds a unanimous Strong Buy on the analyst consensus, with 3 buy ratings given in the last two weeks. Shares are selling for a low $4, but the average price target of $24 suggests an upside potential of 500%. It’s an indication of the high profits possible in the biotech industry.Superior Industries International, Inc. (SUP)Our third stock today may surprise you – it’s an industrial company, part of the supply chain for Detroit’s auto industry. The Motor City may not be what it once was, but it’s hardly down and out, and whether they go electric, alt fuel, or stick with gasoline, cars are always going to need wheels.That’s where Superior comes in. SUP is the leading manufacturer and supplier of cast aluminum wheels to the auto makers. Slowing net sales have led to declines in year-over-year income, however, and the company is facing a rough time. On the positive side, SUP showed a strong positive cash flow in Q2, and paid down $26.1 million in debt principal. CEO Majdi Abulaban said, of Q2, “In light of the persistent volume weakness, we are taking action to right size costs... As a result of these actions, we have reduced production schedules in certain facilities and realized an improvement in working capital and cash flow, which supported sizeable debt principal reductions in the second quarter… We are confident that the initiatives we are implementing, including reducing capital expenditures, will further enhance cash generation for continued debt paydown in 2019.”Watching from Wall Street, B. Riley FBR analyst Christopher Van Horn agrees that SUP has an upbeat outlook going forward. He writes, “We recognize that the company is exposed to production decreases in both North America and Europe. However, our thesis revolves around the company’s ability to manage a difficult top- line environment through better execution on the operating line. We are maintaining our Buy recommendation given that we think the company can improve their sales mix as program launches this year are likely on larger SUVs with higher priced wheels.”Van Horn gives SUB shares a $9 price target to go along with his buy rating, indicating confidence in a high 287% upside to the stock. (To watch Van Horn's track record, click here)Overall, SUP maintains a Moderate Buy from the analyst consensus, based on 2 buys assigned in the last 10 days. The stock sells for only $2.32, so the average price target, $8, suggests a potential upside of 244%.

  • ACCESSWIRE

    CLASS ACTION UPDATE for FRED, CARB and TWOU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

    NEW YORK, NY / ACCESSWIRE / August 18, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine ...

  • GlobeNewswire

    SHAREHOLDER ALERT: CLAIMSFILER REMINDS CAH, CARB, MMM, VNTR INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

    NEW ORLEANS, Aug. 16, 2019 -- ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: 3M.

  • ACCESSWIRE

    SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Carbonite, Inc. and Encourages Investors with Losses to Contact the Firm

    LOS ANGELES, CA / ACCESSWIRE / August 16, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Carbonite, Inc. (“Carbonite” ...

  • ACCESSWIRE

    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Carbonite, Inc. - CARB

    NEW YORK, NY / ACCESSWIRE / August 16, 2019 / Pomerantz LLP is investigating claims on behalf of investors of Carbonite, Inc. (“Carbonite” or the “Company”) (NASDAQ:CARB). Such investors are advised to ...

  • ACCESSWIRE

    SHAREHOLDER ALERT: CARB TWOU EVH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

    NEW YORK, NY / ACCESSWIRE / August 16, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a ...

  • GlobeNewswire

    Carbonite, Inc. (CARB), Cardinal Health, Inc. (CAH) & Just Energy Group Inc. (JE) – Class Action - Bronstein, Gewirtz & Grossman, LLC

    Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. If you suffered a loss, you can request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

  • GlobeNewswire

    Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Carbonite, Inc. – CARB

    Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Carbonite, Inc. (CARB) from February 7, 2019 through July 25, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Carbonite investors under the federal securities laws. If you wish to serve as lead plaintiff, you must move the Court no later than September 30, 2019.

  • ACCESSWIRE

    CLASS ACTION UPDATE for CARB, TWOU and EVH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

    NEW YORK, NY / ACCESSWIRE / August 16, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine ...

  • ACCESSWIRE

    Carbonite, Inc. (CARB), Cardinal Health, Inc. (CAH) & Just Energy Group Inc. (JE) - Class Action Reminder- Bronstein, Gewirtz & Grossman, LLC

    NEW YORK, NY / ACCESSWIRE / August 16, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review ...

  • ACCESSWIRE

    FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CARB, ABMD and TWOU

    CEDARHURST, NY / ACCESSWIRE / August 16, 2019 / The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.

  • ACCESSWIRE

    LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Carbonite, Inc. To Contact The Firm

    NEW YORK, NY / ACCESSWIRE / August 16, 2019 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Carbonite, Inc. ("Carbonite" or the "Company")(CARB) of the September 30, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you invested in Carbonite stock or options between February 7, 2019 and July 25, 2019 and would like to discuss your legal rights, click here: www.faruqilaw.com/CARB. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

  • ACCESSWIRE

    The Gross Law Firm Announces Class Actions on Behalf of Shareholders of STG, DBD and CARB

    NEW YORK, NY / ACCESSWIRE / August 15, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Investors Affected : shareholders of Sunlands Technology Group who purchased shares pursuant and/or traceable to Sunlands’ March 2018 initial public stock offering.

  • Business Wire

    ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Carbonite, Inc. Investors of Important Deadline in Securities Class Action – CARB

    Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Carbonite, Inc. from February 7, 2019 through July 25, 2019, inclusive of the important September 30, 2019 lead plaintiff deadline in the case.

  • ACCESSWIRE

    The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of JE, CARB and TWOU

    NEW YORK, NY / ACCESSWIRE / August 15, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate ...

  • ACCESSWIRE

    INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Carbonite, Inc. and Encourages Investors with Losses to Contact the Firm

    LOS ANGELES, CA / ACCESSWIRE / August 15, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Carbonite, Inc. (“Carbonite” ...

  • GlobeNewswire

    FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of KPTI, EGBN, CARB and CAH

    The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.

  • GlobeNewswire

    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ideanomics, Carbonite, and GTT Communications and Encourages Investors to Contact the Firm

    Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Ideanomics, Inc. (IDEX), Carbonite, Inc. (CARB), and GTT Communications, Inc. (GTT). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.

  • ACCESSWIRE

    FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of VERB, CARB and ABMD

    CEDARHURST, NY / ACCESSWIRE / August 14, 2019 / The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.